Hidradenitis suppurativa
Top Cited Papers
Open Access
- 29 July 2009
- journal article
- Published by Wiley in Journal of the European Academy of Dermatology and Venereology
- Vol. 23 (9) , 985-998
- https://doi.org/10.1111/j.1468-3083.2009.03356.x
Abstract
Hidradenitis suppurativa is a chronic disease characterized by recurrent, painful, deep-seated, rounded nodules and abscesses of apocrine gland-bearing skin. Subsequent suppuration, sinus tracts and hypertrophic scarring are its main features. Onset is usually after puberty, although it is most common during the third decade and may persist in old age. The disease tends to be chronic and may develop to subcutaneous extension leading to indurations, sinus, and fistula having a profound impact on the quality of life. The prevalence is 1% in several studies. Axillary and inguinal involvement is more common in females; peri-anal and buttocks localizations are prevalent in males. The exact aetiology remains unknown. The primary event is a follicular occlusion with secondary inflammation, infection and destruction of the pilo-sebaceo-apocrine apparatus and extension to the adjacent sub-cutaneous tissue. Infection is common. Smoking may be a triggering factor. Obesity aggravates the discomfort. Differential diagnostic includes Crohn's disease, nodular acne and furonculosis. The main complications are arthropathy, carcinoma. Treatment depends upon the stage of the disease. Early nodular lesions may be treated by antibiotics for acute stage; long-term antibiotics, zinc salts may be useful as maintenance treatment; anti-TNF drugs have been used in severe cases; systemic steroids, estrogens, anti-androgens, retinoids have been used as options with limited success. Surgical treatment includes incision with or without drainage for limited abscesses; limited excisions are used for locally recurring draining sinuses. Total wide excision and healing with secondary intention or flaps and grafts is the only curative procedure in case of advanced disease. Conflicts of interest None declared.Keywords
This publication has 72 references indexed in Scilit:
- Clinical characteristics of a series of 302 French patients with hidradenitis suppurativa, with an analysis of factors associated with disease severityJournal of the American Academy of Dermatology, 2009
- A prospective clinical trial of open-label etanercept for the treatment of hidradenitis suppurativaJournal of the American Academy of Dermatology, 2009
- Lack of Association between CARD15 Gene Polymorphisms and Hidradenitis Suppurativa: A Pilot StudyDermatology, 2007
- Quality of life impairment in hidradenitis suppurativa: A study of 61 casesJournal of the American Academy of Dermatology, 2007
- Infliximab for severe hidradenitis suppurativa: Transient clinical efficacy in 7 consecutive patientsJournal of the American Academy of Dermatology, 2007
- The prevalence of hidradenitis suppurativa and its potential precursor lesionsJournal of the American Academy of Dermatology, 1996
- Histology of hidradenitis suppurativaJournal of the American Academy of Dermatology, 1996
- Lithium therapy associated with hidradenitis suppurativa: Case report and a review of the dermatologic side effects of lithiumJournal of the American Academy of Dermatology, 1995
- Effect of localized surgical excisions in hidradenitis suppurativaJournal of the American Academy of Dermatology, 1988
- Topical Treatment of Hidradenitis Suppurativa with ClindamycinInternational Journal of Dermatology, 1983